Advertisement
Screener

Enovis Corp (ENOV) Derivative Asset

2.8 / 5 stars · 68/120 Roast Me

Enovis Corp Derivative Asset

Enovis Corp (ENOV) had Derivative Asset of $34.75 million as of 2025-10-03, per its 10-Q filed 2025-11-06.

Financial Statements › Balance Sheet › Assets

us-gaap:DerivativeAssets · last filed 2025-11-06

  • 2025-10-03: Derivative Asset $34.75M.
  • 2025-07-04: Derivative Asset $35.40M.
  • 2025-04-04: Derivative Asset $45.90M.
  • 2024-12-31: Derivative Asset $35.38M.
Period endDerivative Asset
2025-10-03$34.75M
10-Q · filed 2025-11-06
2025-07-04$35.40M
10-Q · filed 2025-08-07
2025-04-04$45.90M
10-Q · filed 2025-05-08
2024-12-31$35.38M
10-Q · filed 2025-11-06
2024-09-27$33.62M
10-Q · filed 2024-11-06
2024-06-28$10.94M
10-Q · filed 2024-08-07
2024-03-29$8.75M
10-Q · filed 2024-05-02
2023-12-31$34.80M
10-K · filed 2025-02-26
2022-12-31$0.00
10-K · filed 2024-02-22

Similar stocks

Stock NameCountryMarket CapPE Ratio
Cadre Holdings, Inc. (CDRE)United States$1.123B33.88
Anteris Technologies Global Corp. (AVR)United States$0.746B
Sanara MedTech Inc. (SMTI)United States$0.323B-6.81
ESTABLISHMENT LABS HOLDINGS INC. (ESTA)$1.954B-65.76
Inogen Inc (INGN)United States$0.139B-7.00
Conexeu Sciences Inc. (CNXU)United States$0.111B
NutriBand Inc. (NTRB)United States$0.109B
LAKELAND INDUSTRIES INC (LAKE)United States$0.104B-4.21
Safe Pro Group Inc. (SPAI)United States$0.090B
MYOMO, INC. (MYO)United States$0.065B-2.85